KELYA trades 32.0% below Wall Street's consensus target of $15.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes KELYA achieves its forward estimates and maintains a stable P/E multiple of 12.6x. This scenario reflects the blended consensus of 5 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 21, 2026, Kelly Services, Inc. (KELYA) has a Wall Street consensus price target of $15.00, based on estimates from 5 covering analysts. With the stock currently trading at $11.36, this represents a potential upside of +32.0%. The company has a market capitalization of $394M.
Analyst price targets range from a low of $15.00 to a high of $15.00, representing a 0% spread in expectations. The median target of $15.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 3 analysts rating the stock as a Buy or Strong Buy,2 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, KELYA trades at a trailing P/E of -1.6x and forward P/E of 12.6x. Analysts expect EPS to grow +111.7% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
MANManpowerGroup Inc. | $1.6B | $33.55 | $37.86 | +12.8% | Hold | 9.1x | 29 |
RHIRobert Half International Inc. | $3.2B | $31.59 | $40.67 | +28.7% | Hold | 23.9x | 25 |
ASGNASGN Incorporated | $895M | $20.96 | $37.60 | +79.4% | Hold | 5.8x | 13 |
TBITrueBlue, Inc. | $203M | $6.70 | $5.50 | -17.9% | Buy | — | 10 |
KFRCKforce Inc. | $830M | $45.39 | $71.00 | +56.4% | Hold | 18.9x | 10 |
NSPInsperity, Inc. | $1.4B | $36.22 | $52.00 | +43.6% | Hold | 17.6x | 8 |
CCRNCross Country Healthcare, Inc. | $426M | $13.17 | $12.50 | -5.1% | Hold | 142.4x | 14 |
AMNAMN Healthcare Services, Inc. | $1.2B | $30.98 | $27.00 | -12.8% | Buy | 11.6x | 17 |
HCSGHealthcare Services Group, Inc. | $1.6B | $22.94 | $24.50 | +6.8% | Hold | 21.2x | 15 |
ADPAutomatic Data Processing, Inc. | $87.9B | $218.41 | $243.63 | +11.5% | Hold | 19.7x | 36 |
Quick answers to the most common questions about buying KELYA stock.
The consensus Wall Street price target for KELYA is $15, representing 32.0% upside from the current price of $11.36. With 5 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
KELYA has a consensus rating of "Buy" based on 5 Wall Street analysts. The rating breakdown is predominantly bullish, with 3 Buy/Strong Buy ratings. The consensus 12-month price target of $15 implies 32.0% upside from current levels.
With a forward P/E of 12.5873x, KELYA trades at a relatively low valuation. The consensus target of $15 implies 32.0% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $15 for KELYA, while the most conservative target is $15. The consensus of $15 represents the median expectation. These targets typically reflect 12-month expectations.
KELYA is moderately covered, with 5 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 3 have Buy ratings, 2 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month KELYA stock forecast based on 5 Wall Street analysts shows a consensus price target of $15, with estimates ranging from $15 (bear case) to $15 (bull case). The median consensus rating is "Buy".
KELYA trades at a forward P/E ratio of 12.6x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on KELYA, with a "Buy" consensus rating and $15 price target (32.0% upside). 3 of 5 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
KELYA analyst price targets range from $15 to $15, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $15 consensus represents the middle ground.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.